{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"How Parity and Breastfeeding May Guard Against Triple-Negative Breast Cancer","description":"In this episode of MD Newsline, Dr. Sherene Loi, a medical oncologist and laboratory head at the Peter MacCallum Cancer Centre in Melbourne, Australia, discusses groundbreaking research published in Nature exploring how pregnancy and breastfeeding influence immune protection against triple-negative breast cancer. Dr. Loi shares insights into how reproductive history reshapes the immune system, particularly T cell activity, and how these findings may inform future prevention strategies, screening approaches, and immunotherapy development. Episode Highlights: The Immune System\u2019s Role in Triple-Negative Breast Cancer Dr. Loi explains why the immune system is critical in triple-negative breast cancer, a subtype known to respond well to immunotherapy. Her research focuses on immune cell infiltration, particularly T cells, and how immune surveillance affects tumor growth and patient outcomes. How Pregnancy and Breastfeeding Enhance T Cell Immunity The study reveals that women who have experienced pregnancy and breastfeeding have significantly higher T cell levels in normal, cancer-unaffected breast tissue. Dr. Loi walks through both human tissue analysis and mouse model data demonstrating that this immune enrichment plays a protective role against tumor development. Evidence from Preclinical and Clinical Models Dr. Loi describes experiments showing that tumors grow more slowly in mice that have undergone pregnancy, lactation, and involution. She also explains how T cell depletion removes this protective effect, confirming that immunity\u2014rather than hormones alone\u2014drives this benefit. Implications for High-Risk and Diverse Populations The protective immune effect was observed regardless of BRCA1 or BRCA2 mutation status. Dr. Loi also discusses how these findings may help explain differences in triple-negative breast cancer risk across populations and highlight the importance of breastfeeding support at a public health level. Toward Preventative Immunotherapy and Vaccines This research introduces a paradigm shift\u2014from treating cancer to preventing it. Dr. Loi explores the potential for vaccines or immune-based therapies that mimic pregnancy-related immune reprogramming and emphasizes the importance of collecting reproductive history in oncology care and clinical trials. Future Directions: Screening, Technology, and Policy Dr. Loi discusses how reproductive history may influence response to immunotherapy, inform personalized screening strategies, and shape future research using AI, T cell receptor profiling, and blood-based early detection tests. She also underscores the societal importance of supporting breastfeeding through policy and workplace initiatives. Key Takeaway Dr. Loi highlights that pregnancy and breastfeeding create long-lasting, systemic immune changes that may protect against triple-negative breast cancer. Understanding how reproductive history reshapes immune surveillance opens new avenues for prevention, personalized treatment, and population-level strategies to reduce the global burden of breast cancer. Resources: Website: https:\/\/mdnewsline.com\/ Newsletter: https:\/\/mdnewsline.com\/subscribe\/ Connect with Dr. Sherene Loi:  Here ","author_name":"MD Newsline","author_url":"http:\/\/sites.libsyn.com\/491927","html":"